Feng-yun Zhong

  • Citations Per Year
Learn More
يناثلا ىفشتسلما ،ةماعلا ةحارلجا مسق يف يدعبلا ليلحتلا اذه يرجأ :ةقيرطلا انمق دقل .م2014 ماع يف ينصلا ،وسغنايج ةعطاقم ،وجوس ،وكوس ةعمالج عباتلا ،نيلاديم تانايب ةدعاق يف كلذو عوضولماب طبترلما يملعلا بدلأا يف ثحبلاب ةرتفلا للاخ كلذو يويلحا بطلل ةينيصلا تانايبلا ةدعاقو ،نيركوكو ،سيبيمإو تاملكلاو نيوانعلا مادختساب ثحبلا اذهب انمق دقل .م2014 ىلإ م1990 نم نولوقلا(More)
OBJECTIVE To investigate the expression of cyclooxygenase-2(COX-2) and CEA in the tissues adjacent to the tumor within different distances. METHODS A total of 42 colorectal cancer tissues were collected.The adjacent tissues within 3 cm to the tumor were procured every 1 cm. Normal tissue was also collected. RNA was extracted and the expression of CEA and(More)
OBJECTIVE To investigate the correlation of single nucleotide polymorphisms (SNP) of XRCC1 gene to hereditary susceptibility of colorectal cancer. METHODS XRCC1 genotypes in 124 colorectal cancer patients and 214 matched healthy people as control were analyzed by SnaP Shot SNP-typing technique. Five different inheritance models including codominant,(More)
AIM To investigate the effects of small interfering RNA (siRNA)-mediated inhibition of Class I phosphoinositide 3-kinase (Class I PI3K) signal transduction on the proliferation, apoptosis, and autophagy of gastric cancer SGC7901 and MGC803 cells. METHODS We constructed the recombinant replication adenovirus PI3K(I)-RNA interference (RNAi)-green(More)
Concurrent radiotherapy and chemotherapy is the main treatment for locally advanced non-small cell lung cancer. Acute Radiation Pneumonitis (ARP) is one of the most important complications of radiotherapy for lung cancer and is difficult to treat and causes high mortality rates. In this study, we reported a patient with grade IV ARP who underwent 2 months(More)
Circulating cell-free DNA (ccf-DNA) in plasma may contain both specific and non-specific of tumor markers. The concentration and integrity of ccf-DNA may be clinical useful for detecting and predicting cancer progression. Plasma samples from 40 healthy controls and 73 patients with gastric cancers (two stage 0, 17 stage I, 11 stage II, 33 stage III, and 10(More)
  • 1